Angelo Antonini

38.9k total citations · 4 hit papers
529 papers, 21.0k citations indexed

About

Angelo Antonini is a scholar working on Neurology, Cellular and Molecular Neuroscience and Cognitive Neuroscience. According to data from OpenAlex, Angelo Antonini has authored 529 papers receiving a total of 21.0k indexed citations (citations by other indexed papers that have themselves been cited), including 442 papers in Neurology, 103 papers in Cellular and Molecular Neuroscience and 66 papers in Cognitive Neuroscience. Recurrent topics in Angelo Antonini's work include Parkinson's Disease Mechanisms and Treatments (408 papers), Neurological disorders and treatments (314 papers) and Botulinum Toxin and Related Neurological Disorders (70 papers). Angelo Antonini is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (408 papers), Neurological disorders and treatments (314 papers) and Botulinum Toxin and Related Neurological Disorders (70 papers). Angelo Antonini collaborates with scholars based in Italy, United Kingdom and United States. Angelo Antonini's co-authors include Gianni Pezzoli, Klaus L. Leenders, Per Odin, К. Ray Chaudhuri, David Eidelberg, Roberta Biundo, Pablo Martínez‐Martín, Werner Poewe, Luca Weis and Vijay Dhawan and has published in prestigious journals such as New England Journal of Medicine, Journal of Neuroscience and SHILAP Revista de lepidopterología.

In The Last Decade

Angelo Antonini

511 papers receiving 20.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Valvular Heart Disease and the Use of Dopamine Agonists for Parkinson's Disease

2007 575 citations Angelo Antonini et al. profile →
Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study

2013 487 citations Per Odin, Angelo Antonini et al. profile →
European Academy of Neurology/Movement Disorder Society‐European Section Guideline on the Treatment of Parkinson's Disease: I. Invasive Therapies

2022 100 citations Günther Deuschl, Angelo Antonini et al. Movement Disorders profile →
Parkinson disease therapy: current strategies and future research priorities

2024 49 citations Fabrizio Stocchi, Angelo Antonini et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Angelo Antonini	15.8k	5.4k	3.5k	2.1k	2.0k	529	21.0k
Paolo Barone	12.3k 0.8×	4.2k 0.8×	3.4k 1.0×	1.6k 0.8×	2.7k 1.4×	418	17.6k
Anette Schrag	16.6k 1.0×	4.5k 0.8×	3.1k 0.9×	2.4k 1.1×	3.3k 1.7×	308	22.4k
J. Eric Ahlskog	13.3k 0.8×	5.2k 1.0×	2.4k 0.7×	1.9k 0.9×	2.1k 1.1×	279	19.9k
Olivier Rascol	20.8k 1.3×	7.7k 1.4×	4.7k 1.3×	2.3k 1.1×	2.7k 1.4×	434	27.5k
Glenn T. Stebbins	12.0k 0.8×	3.0k 0.5×	5.0k 1.4×	1.7k 0.8×	4.0k 2.0×	271	18.1k
Thomas Foltynie	15.4k 1.0×	7.4k 1.4×	4.6k 1.3×	851 0.4×	1.5k 0.7×	284	20.6k
Wolfgang H. Oertel	15.9k 1.0×	6.0k 1.1×	3.6k 1.0×	2.5k 1.2×	2.2k 1.1×	292	23.4k
Klaus Seppi	16.3k 1.0×	6.0k 1.1×	2.7k 0.8×	2.3k 1.1×	1.9k 1.0×	296	21.1k
Bruno Dubois	12.0k 0.8×	3.4k 0.6×	4.1k 1.2×	1000 0.5×	3.1k 1.6×	106	17.1k
Charles H. Adler	19.5k 1.2×	5.3k 1.0×	4.3k 1.2×	2.4k 1.2×	3.4k 1.7×	313	25.7k

Countries citing papers authored by Angelo Antonini

Since Specialization

Citations

This map shows the geographic impact of Angelo Antonini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angelo Antonini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angelo Antonini more than expected).

Fields of papers citing papers by Angelo Antonini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angelo Antonini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angelo Antonini. The network helps show where Angelo Antonini may publish in the future.

Co-authorship network of co-authors of Angelo Antonini

This figure shows the co-authorship network connecting the top 25 collaborators of Angelo Antonini. A scholar is included among the top collaborators of Angelo Antonini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angelo Antonini. Angelo Antonini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Monje, Mariana H.G., Sylvie Grosjean, Raquel Bouça‐Machado, et al.. (2025). Insights From a Mixed Methods Analysis of 3 Health Technologies Used in Patients With Parkinson Disease: Mixed Methods Study. Journal of Medical Internet Research. 27. e67986–e67986.

Ferreira, Joaquim J., Olivier Rascol, Fabrizio Stocchi, et al.. (2025). Opicapone as adjunct to levodopa in treated Parkinson's disease without motor complications: A randomized clinical trial. European Journal of Neurology. 32(1). e16420–e16420. 2 indexed citations

Fiorenzato, Eleonora, Silvia Zabberoni, Maria Stefania De Simone, et al.. (2025). Effects of virtual reality cognitive training on executive function and prospective memory in Parkinson's disease and healthy aging. Journal of the Neurological Sciences. 473. 123507–123507. 2 indexed citations

Burgio, Francesca, Arianna Menardi, Silvia Benavides‐Varela, et al.. (2024). Facial emotion recognition in individuals with mild cognitive impairment: An exploratory study. Cognitive Affective & Behavioral Neuroscience. 24(3). 599–614. 5 indexed citations

Hamid, Eman, et al.. (2024). Role of zonisamide in advanced Parkinson’s disease: a randomized placebo-controlled study. Neurological Sciences. 45(4). 1725–1734. 2 indexed citations

Weis, Luca, Eleonora Fiorenzato, Margherita Canesi, et al.. (2024). Validation of the Italian version of the Parkinson’s Disease- Cognitive Functional Rating Scale. Journal of Neural Transmission. 131(4). 305–314. 3 indexed citations

Bordin, Anna, Giancarlo Ottaviano, Piergiorgio Gaudioso, et al.. (2024). Late olfactory bulb involvement in COVID-19. Chemical Senses. 49. 1 indexed citations

Antonini, Angelo, Heinz Reichmann, Giovanni Gentile, et al.. (2023). Toward objective monitoring of Parkinson's disease motor symptoms using a wearable device: wearability and performance evaluation of PDMonitor®. Frontiers in Neurology. 14. 1080752–1080752. 33 indexed citations

Bordin, Anna, Gabriele Sales, Alberto Biscontin, et al.. (2023). Persistent and transient olfactory deficits in COVID-19 are associated to inflammation and zinc homeostasis. Frontiers in Immunology. 14. 1148595–1148595. 5 indexed citations

10.

Fiorenzato, Eleonora, et al.. (2023). Brain Dynamics Complexity as a Signature of Cognitive Decline in Parkinson's Disease. Movement Disorders. 39(2). 305–317. 20 indexed citations

11.

Fabbri, Margherita, et al.. (2022). Personalized Care in Late-Stage Parkinson’s Disease: Challenges and Opportunities. Journal of Personalized Medicine. 12(5). 813–813. 8 indexed citations

12.

Deuschl, Günther, Angelo Antonini, João Costa, et al.. (2022). European Academy of Neurology/Movement Disorder Society‐European Section Guideline on the Treatment of Parkinson's Disease: I. Invasive Therapies. Movement Disorders. 37(7). 1360–1374. 100 indexed citations breakdown →

13.

Deuschl, Günther, Angelo Antonini, João Costa, et al.. (2022). European Academy of Neurology/Movement Disorder Society ‐ European Section guideline on the treatment of Parkinson's disease: I. Invasive therapies. European Journal of Neurology. 29(9). 2580–2595. 48 indexed citations

14.

Marcante, Andrea, Roberto Di Marco, Giovanni Gentile, et al.. (2020). Foot Pressure Wearable Sensors for Freezing of Gait Detection in Parkinson’s Disease. Sensors. 21(1). 128–128. 50 indexed citations

15.

Modugno, Nicola, Angelo Antonini, Alessandro Tessitore, et al.. (2020). <p>Impact of Supporting People with Advanced Parkinson’s Disease on Carer’s Quality of Life and Burden</p>. Neuropsychiatric Disease and Treatment. Volume 16. 2899–2912. 10 indexed citations

16.

Fabbri, Margherita, Miguel Coelho, Daisy Abreu, et al.. (2019). Dysphagia predicts poor outcome in late-stage Parkinson's disease. Parkinsonism & Related Disorders. 64. 73–81. 29 indexed citations

17.

Biundo, Roberta, Eleonora Fiorenzato, & Angelo Antonini. (2017). Nonmotor Symptoms and Natural History of Parkinson's Disease: Evidence From Cognitive Dysfunction and Role of Noninvasive Interventions. International review of neurobiology. 133. 389–415. 13 indexed citations

18.

Odin, Per, et al.. (2017). Device-Aided Treatment Strategies in Advanced Parkinson's Disease. International review of neurobiology. 132. 453–474. 40 indexed citations

19.

Dafsari, Haidar S., Paul Reker, Monty Silverdale, et al.. (2017). Quality of life outcome after subthalamic stimulation in Parkinson's disease depends on age. Movement Disorders. 33(1). 99–107. 33 indexed citations

20.

Rizos, Alexandra, Y. Naidu, Anthony H.V. Schapira, et al.. (2011). Pain in Parkinson's disease: Observational study of 225 patients. UCL Discovery (University College London). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact